*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide</strong> is a high-purity heterocyclic intermediate primarily synthesized via cyclocondensation and selective chlorination. This compound serves as a critical scaffold for kinase inhibitors, with the molecular formula C14H18ClN5O and CAS number 1039478-59-4.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical R&D: Precursor for novel ATP-competitive kinase inhibitors targeting oncology indications.</li>
<li>Medicinal Chemistry: Structural core in library synthesis for optimizing binding affinity and metabolic stability.</li>
<li>Custom Manufacturing: Bulk supply for contract development organizations (CDMOs) producing active pharmaceutical ingredients.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent hydrolysis. Personnel must utilize PPE including nitrile gloves and fume hoods due to potential sensitization risks. Not intended for direct clinical use without further derivatization.</p>